We exist to improve the lives
of everyone affected by epilepsy

Epilepsy Today

EMA public hearing on valproate-based medicines open for applications from EU citizens

14 Jul 2017

The European Medicines Agency (EMA) is holding a public hearing on medicines containing valproate on 26 September 2017 at its London offices.

The EMA assesses and oversees the safety of medicines in the EU. The announced public hearing is part of the EMA’s review into the use of valproate-based medicines in women who are pregnant or of childbearing age.

Some versions of levetiracetam out of stock

10 Jul 2017

The following versions of levetiracetam are currently out of stock in the UK:

Accord 100mg tablets. Accord does not know when they will be back in stock.

Accord 250mg tablets. Due back in stock from October 2017.

Accord 500mg tablets. Due back in stock from August 2017.

Accord 750mg tablets. Accord does not know when they will be back in stock.

Accord 1000mg tablets. Accord does not know when they will be back in stock.

Actavis 250mg tablets. Actavis does not know when they will be back in stock.

Prolonged release acetazolamide capsules out of stock

6 Jul 2017

The following prolonged release acetazolamide capsules are out of stock in the UK:

    • Diamox SR 250mg prolonged release capsules, made by Concordia International
    • Eytazox 250mg prolonged release capsules, made by Auden McKenzie

Both companies expect to have these medicines back in stock at the end of September.

Normal release acetazolamide tablets, called Diamox without SR in the name, are still in stock.

Glasgow woman with epilepsy breaks cycling records to raise epilepsy awareness

6 Jul 2017

Ultra-marathon cyclist Katie Ford has broken 2 cycling world records, pending verification, and 2 British records to raise awareness of epilepsy.

On 2 July, Katie, 31, took to the Sir Chris Hoy Velodrome in Glasgow’s Emirates Arena to try to break the 6, 8 and 12-hour indoor track cycling world records. Katie broke two world records for 6 and 8-hour track cycling, pending verification.

Pregabalin supply problems

16 Jun 2017

Some versions of pregabalin are low in stock.

Pfizer’s liquid version of pregabalin – called Lyrica – is low in stock. This is because of a problem with the bottle closure. Pfizer are not expecting any new stock until at least July 2017.

TEVA’s version of pregabalin is also very low in stock in all doses. TEVA do not know when they will have more in stock.

Other versions of pregabalin marketed by Actavis (under the brand name Lecaent) and Consilient (under the brand name Rewisca) currently have no supply problems.

Sunshine on the window: The butterfly effect

25 May 2017

Jasmine Forrest is a 25-year-old journalism student from Manchester. Throughout the years following her epilepsy diagnosis at age 17, she has experienced many highs and lows when dealing with (and accepting) her condition. Eight years on, she has decided to speak out about her feelings, thoughts and experiences as a young woman with epilepsy through her blog: Sunshine on the window. 

 

Pages